drugset
drugset / Trial / NCT05800938

The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial

NCT05800938 ↗

Phase 4 Completed 46 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

Will follow up umblical artery Doppler indices for pregnancies with iugr taking placebo and oral isosorbide mononitrate to study its efficacy on the intrauterine growth restricted fetuses

Timeline

Start
2022-06-08
Primary completion
2022-12-06
Completion
2022-12-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isosorbide Mononitrate Other / unclassified 30 mg Oral

Indications

fetal growth restriction